Table 2

Patient demographics

All patientsCOPAFOPGOPp Value
Number of patients61361015n.s.
Average age (years)61.560.359.662.6n.s.
Male sex (%)35 (57)25 (69)4 (40)6 (40)n.s.
Caucasian (%)53 (87)30 (83)9 (90)14 (93)n.s.
Any history of cancer (%)43 (70)25 (69)10 (100)8 (53)0.05
Active cancer (%)16 (26)10 (28)5 (50)1 (7)n.s.
Prior radiation (%)18 (30)9 (25)6 (60)3 (20)n.s.
Median time from radiation (months)13.57.94.5143n.s.
Prior chemotherapy (%)27 (44)15 (42)8 (80)4 (27)0.03
Median time from chemotherapy (months)3.02.72.576.5n.s.
Ever smoker36 (59)19 (53)5 (50)12 (80)n.s.
  Ex-smoker (% of all smokers)32 (89)16 (84)4 (80)12 (100)n.s.
 Active smoker (% of all smokers)4 (11)3 (16)1 (20)0 (0)n.s.
  Median pack-years30453025.5n.s.
Any respiratory symptom (%)32 (52)20 (56)6 (60)6 (40)n.s.
Respiratory failure (%)3 (5)1 (3)2 (20)0 (0)n.s.
Medication prescribed (%)*15 (25)10 (28)3 (30)2 (13)n.s.
  Steroids (% of all medications)14 (93)9 (90)3 (100)2 (100)n.s.
  Macrolides (% of all medications)4 (27)2 (20)02 (100)n.s.
 Azathioprine (% of all medications)3 (20)3 (20)00n.s.
Death (%)14 (23)9 (25)4 (40)1 (7)n.s.
  Death due to organising pneumonia (% of all deaths)1 (7)1 (11)0 (0)0 (0)n.s.
  • *Seven patients received multiple medication forms (five with COP, two with GOP).

  • AFOP, acute fibrinous and organising pneumonia; COP, cryptogenic organising pneumonia; GOP, granulomatous organising pneumonia.